Cholestatic jaundice due to congenital Toxoplasma gondii infection

S Singh1, R Lodha, G R Passi

  • 1Department of Laboratory Medicine, All India Institute of Medical Sciences, New Delhi, India.

Insights

Congenital toxoplasmosis can cause hepatosplenomegaly and cholestatic jaundice in infants. This case highlights successful treatment of congenital toxoplasmosis with a sulphadiazine and pyremethamine combination.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Medical Parasitology

Background:

  • Congenital toxoplasmosis is a parasitic infection passed from mother to child during pregnancy.
  • Clinical manifestations in infants can vary widely, often presenting non-specifically.
  • Hepatosplenomegaly and jaundice are recognized, though less common, signs of congenital toxoplasmosis.

Observation:

  • A 4-month-old infant presented with significant hepatosplenomegaly and cholestatic jaundice.
  • The clinical presentation suggested a serious underlying condition requiring prompt diagnosis.
  • Diagnostic workup confirmed the etiology as congenital toxoplasmosis.

Findings:

  • This case represents the first reported instance of cholestatic jaundice secondary to congenital toxoplasmosis in India.
  • The infant's symptoms, including liver and spleen enlargement and jaundice, were attributed to the parasitic infection.
  • Laboratory and clinical findings were consistent with a severe presentation of congenital toxoplasmosis.

Implications:

  • Early diagnosis and treatment are crucial for improving outcomes in congenital toxoplasmosis.
  • This report expands the known clinical spectrum of congenital toxoplasmosis in neonates and infants.
  • The successful treatment with sulphadiazine and pyremethamine underscores the efficacy of standard antiparasitic regimens.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...